TY -的T1 - Nontuberculosis分枝杆菌感染ions: would there be pharmacodynamics without pharmacokinetics? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01508-2019 VL - 54 IS - 5 SP - 1901508 AU - Kim, Hannah Yejin AU - Sintchenko, Vitali AU - Alffenaar, Jan-Willem Y1 - 2019/11/01 UR - //www.qdcxjkg.com/content/54/5/1901508.abstract N2 - We read with great interest the recent publication by Kwak et al. [1] involving a meta-analysis of studies reporting treatment outcomes for Mycobacterium abscessus pulmonary disease (MAB-PD). The authors should be commended for identifying the association between azithromycin, amikacin and imipenem, and improved clinical outcome in MAB-PD.A combination of pharmacokinetics and pharmacodynamics is required to evaluate the efficacy of antimicrobial drugs in the treatment of Mycobacterium abscessus http://bit.ly/2OGwS3C ER -